PSILOCYBIN-ASSISTED PSYCHOTHERAPY FOR THE TREATMENT OF DEPRESSION AND ANXIETY
PRISM is currently researching psilocybin-assisted psychotherapy, in partnership with St Vincent’s Hospital Melbourne. The aim of this study is to examine the psychotherapeutic potential of psilocybin-assisted psychotherapy for treatment of Australian cancer and palliative care patients, experiencing depression and anxiety. This study commenced in January 2020 and will take three years to complete.
PRISM is currently working with Edith Cowan University in Perth on a proposed proof of concept study of MDMA-Assisted Manualised Psychotherapy for treatment-resistant Posttraumatic Stress Disorder (PTSD), in collaboration with the US based Multidisciplinary Association for Psychedelic Studies (MAPS). For more information please contact us.
MAPS coordinated MDMA-PTSD studies are currently underway in the USA, Canada and Israel. For information on MAPS studies please visit http://www.maps.org/research/mdma
Global Ayahuasca Project
PRISM is a partner organisation in the Global Ayahuasca Project, a multidisciplinary research project based at the University of Melbourne that is being undertaken by an international team of researchers from Brazil, Spain, the Czech Republic, and Switzerland.
The project aims to increase understanding of the drinking of ayahuasca in different contexts around the globe and will explore motivations and contexts of drinking, reported effects on health and well-being, and any potential risks. A range of research tools will be used to collect information, commencing with the first Global survey of ayahuasca drinking.
If you have drunk ayahuasca please join the project – share your experiences in the Global survey of ayahuasca drinking and help build understanding of the effects of this sacramental tea on the lives of those who consume it.
Strauss, N., Bright, S. J., & Williams, M. L. (2016). Australia should be initiating a psychedelic research program: What are the barriers? Australian and New Zealand Journal of Psychiatry, 50(11), 1036-1037. http://journals.sagepub.com/doi/full/10.1177/0004867416670520
Response (not a PRISM publication): Puspanathan, P. (2017). Psychedelic research in Australia: Breaking through the stigma.
Australian and New Zealand Journal of Psychiatry. http://journals.sagepub.com/doi/pdf/10.1177/0004867417701580
PRISM is not currently hiring. Please subscribe to our mailing list for updates on future opportunities.
For students, we’re sorry to advise that Australia is lagging far beyond other countries in terms of psychedelic research. All PhDs so far have been confined to survey based research or people have travelled overseas. The best advice we can give is to complete your honours in a related field (eg psychology, brain-imaging, neuroscience, anthropology etc) and then seek support to do a PhD.